2023 Form 5500 filing — Breckenridge Pharmaceutical, Inc. 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20241001133333NAL0006827713001) for Breckenridge Pharmaceutical, Inc. 401(K) Plan, reported by Breckenridge Pharmaceutical, Inc. under EIN 65-0352825 and plan number 001. It reports 89 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).
- EFAST2 acknowledgement
- 20241001133333NAL0006827713001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Breckenridge Pharmaceutical, Inc.
- EIN
- 65-0352825
- Plan number
- 001
- Location
- Berkeley Heights, NJ
- Participants
- 89
- Schedules available
- Schedule I
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $12,211,308
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $12,211,308
- Employer contributions
- $327,432
- Participant contributions
- $806,878
- Total income / additions
- $4,059,059
- Benefits paid
- $3,472,098
- Administrative expenses
- $29,196
- Total expenses
- $3,501,294
- Net increase / (decrease)
- $557,765
- Schedule source
- Schedule I